4.4 Article

Validation of the only commercially available immunoassay for synthetic cathinones in urine: Randox Drugs of Abuse V Biochip Array Technology

Journal

DRUG TESTING AND ANALYSIS
Volume 6, Issue 7-8, Pages 728-738

Publisher

WILEY-BLACKWELL
DOI: 10.1002/dta.1633

Keywords

synthetic cathinones; mephedrone; MDPV; Randox; immunoassay

Funding

  1. Department of Defense Counter Narcotics Program
  2. National Institute for Drug Abuse (NIDA), National Institutes of Health (NIH), Department of Health and Human Services (DHHS)

Ask authors/readers for more resources

Deterrence of synthetic cathinone abuse is hampered by the lack of a high-throughput immunoassay screen. The Randox Drugs of Abuse V (DOA-V) Biochip Array Technology contains two synthetic cathinone antibodies: Bath Salt I (BSI) targets mephedrone/methcathinone and Bath Salt II (BSII) targets 3',4'-methylenedioxypyrovalerone (MDPV)/3',4'-methylenedioxy-alpha-pyrrolidinobutiophenone (MDPBP). We evaluated DOA-V synthetic cathinones performance and conducted a full validation on the original assay with calibrators reconstituted in water, and the new assay with calibrators prepared in lyophilized urine; both utilized the same antibodies and were run on the fully automated Evidence (R) Analyzer. We screened 20 017 authentic military urine specimens and confirmed positives by liquid chromatography-tandem mass spectrometry (LC-MS/MS) for 28 synthetic cathinones. Limits of detection (LOD) for the original and new assays were 0.35 and 0.18 (BSI), and 8.5 and 9.2 mu g/L (BSII), respectively. Linearity was acceptable (R-2 > 0.98); however, a large negative bias was observed with in-house prepared calibrators. Intra-assay imprecision was < 20% BSI-II, while inter-assay imprecision was 18-42% BSI and < 22% BSII. Precision was acceptable for Randox controls. Cross-reactivities of many additional synthetic cathinones were determined. Authentic drug-free negative urine pH < 4 produced false positive results for BSI (6.3 mu g/L) and BSII (473 mu g/L). Oxidizing agents reduced BSI and increased BSII results. Sensitivity, specificity, and efficiency of 100%, 52.1%, and 53.0% were obtained at manufacturer's proposed cut-offs (BSI 5 mu g/L, BSII 30 mu g/L). Performance improved if cut-off concentrations increased (BSI 7.5 mu g/L, BSII 40 mu g/L); however, there were limited confirmed positive specimens. Currently, this is the first and only fully validated immunoassay for preliminary detection of synthetic cathinones in urine. Published 2014. This article is a U.S. Government work and is in the public domain in the USA.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available